| UniProt ID | OSTF1_HUMAN | |
|---|---|---|
| UniProt AC | Q92882 | |
| Protein Name | Osteoclast-stimulating factor 1 | |
| Gene Name | OSTF1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 214 | |
| Subcellular Localization | Cytoplasm . | |
| Protein Description | Induces bone resorption, acting probably through a signaling cascade which results in the secretion of factor(s) enhancing osteoclast formation and activity.. | |
| Protein Sequence | MSKPPPKPVKPGQVKVFRALYTFEPRTPDELYFEEGDIIYITDMSDTNWWKGTSKGRTGLIPSNYVAEQAESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSNAEDYLDDEDSD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MSKPPPKPV ------CCCCCCCCC | 54.60 | 25944712 | |
| 21 | Phosphorylation | VKVFRALYTFEPRTP EEEEEEEEEECCCCC | 14.38 | 28152594 | |
| 22 | Phosphorylation | KVFRALYTFEPRTPD EEEEEEEEECCCCCC | 23.52 | 28152594 | |
| 39 | Ubiquitination | YFEEGDIIYITDMSD EECCCCEEEEEECCC | 2.12 | 22505724 | |
| 54 | Phosphorylation | TNWWKGTSKGRTGLI CCCCCCCCCCCCCEE | 41.61 | 21712546 | |
| 56 | Ubiquitination | WWKGTSKGRTGLIPS CCCCCCCCCCCEECC | 31.95 | 22505724 | |
| 58 | Phosphorylation | KGTSKGRTGLIPSNY CCCCCCCCCEECCHH | 45.04 | 21712546 | |
| 63 | Phosphorylation | GRTGLIPSNYVAEQA CCCCEECCHHHHHHH | 33.52 | 21712546 | |
| 65 | Phosphorylation | TGLIPSNYVAEQAES CCEECCHHHHHHHHH | 12.84 | 27642862 | |
| 72 | Phosphorylation | YVAEQAESIDNPLHE HHHHHHHHCCCHHHH | 37.95 | 27067055 | |
| 82 | Acetylation | NPLHEAAKRGNLSWL CHHHHHHHHCCHHHH | 68.81 | 25953088 | |
| 82 | Ubiquitination | NPLHEAAKRGNLSWL CHHHHHHHHCCHHHH | 68.81 | 22505724 | |
| 85 | Ubiquitination | HEAAKRGNLSWLREC HHHHHHCCHHHHHHH | 34.63 | 22505724 | |
| 87 | Phosphorylation | AAKRGNLSWLRECLD HHHHCCHHHHHHHHH | 28.23 | 24719451 | |
| 111 | Phosphorylation | KAGSTALYWACHGGH CCCHHHHHHHHHCCC | 6.62 | 25147952 | |
| 119 | Ubiquitination | WACHGGHKDIVEMLF HHHHCCCHHHHHHHH | 53.04 | 21890473 | |
| 136 | Ubiquitination | PNIELNQQNKLGDTA CCEECCCCCCCCHHH | 48.21 | 21890473 | |
| 152 | Phosphorylation | HAAAWKGYADIVQLL HHHHHCCHHHHHHHH | 9.43 | 28348404 | |
| 162 | Ubiquitination | IVQLLLAKGARTDLR HHHHHHHCCCCHHHH | 53.74 | 23000965 | |
| 165 | Ubiquitination | LLLAKGARTDLRNIE HHHHCCCCHHHHHHH | 37.12 | 21890473 | |
| 174 | Ubiquitination | DLRNIEKKLAFDMAT HHHHHHHHHHHHHHH | 32.05 | 29967540 | |
| 181 | Phosphorylation | KLAFDMATNAACASL HHHHHHHHHHHHHHH | 20.82 | 26552605 | |
| 185 | Glutathionylation | DMATNAACASLLKKK HHHHHHHHHHHHHHH | 2.16 | 22555962 | |
| 187 | Phosphorylation | ATNAACASLLKKKQG HHHHHHHHHHHHHCC | 33.83 | 30576142 | |
| 190 | Ubiquitination | AACASLLKKKQGTDA HHHHHHHHHHCCCCH | 64.32 | 29967540 | |
| 195 | Phosphorylation | LLKKKQGTDAVRTLS HHHHHCCCCHHHHHC | 20.49 | 29514088 | |
| 200 | Phosphorylation | QGTDAVRTLSNAEDY CCCCHHHHHCCHHHH | 28.12 | 20201521 | |
| 202 | Phosphorylation | TDAVRTLSNAEDYLD CCHHHHHCCHHHHCC | 33.12 | 20201521 | |
| 207 | Phosphorylation | TLSNAEDYLDDEDSD HHCCHHHHCCCCCCC | 11.97 | 30278072 | |
| 213 | Phosphorylation | DYLDDEDSD------ HHCCCCCCC------ | 43.08 | 20201521 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 202 | S | Phosphorylation | Kinase | RPS6KA1 | Q15418 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of OSTF1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of OSTF1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MTND_HUMAN | ADI1 | physical | 17353931 | |
| KHDR1_HUMAN | KHDRBS1 | physical | 22745667 | |
| CBL_HUMAN | CBL | physical | 15135048 | |
| SRC_HUMAN | SRC | physical | 15135048 | |
| ACTB_HUMAN | ACTB | physical | 15135048 | |
| A4_HUMAN | APP | physical | 21832049 | |
| TRI54_HUMAN | TRIM54 | physical | 25416956 | |
| XRP2_HUMAN | RP2 | physical | 28514442 | |
| KLH42_HUMAN | KLHL42 | physical | 28514442 | |
| MYO1E_HUMAN | MYO1E | physical | 28514442 | |
| PXDNL_HUMAN | PXDNL | physical | 28514442 | |
| CHM2A_HUMAN | CHMP2A | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-200 AND SER-213, ANDMASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-200; SER-202 ANDSER-213, AND MASS SPECTROMETRY. | |
| "Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-200 AND SER-213, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-202 AND SER-213, ANDMASS SPECTROMETRY. | |
| "Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-202 AND SER-213, ANDMASS SPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-202 AND SER-213, ANDMASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-213, AND MASSSPECTROMETRY. | |